If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Portfolio Update

15 Dec 2017 07:00

RNS Number : 4344Z
Ranger Direct Lending Fund PLC
15 December 2017
 

 

15 December 2017

RANGER DIRECT LENDING FUND PLC (the "Company")

Portfolio Update

Further to the Company's announcements regarding the bankruptcy proceedings in respect of Argon Credit, LLC and Argon X, LLC (together, "Argon"), the Company has received additional information regarding its investment in Princeton Alternative Income Fund Ltd ("Princeton").

Having reviewed the information provided prior and pursuant to the arbitration proceedings thus far, the Company has determined in accordance with its valuation policy to unilaterally take an additional gross reserve of US $9.1 million against its indirect investment in the Argon portfolio. The total amount of fees to be credited to the net asset value of the Company from both Princeton and its investment manager are approximately US $2.1 million. These are the total credited fees associated with the gross reserve of US $9.1 million announced today and the gross reserve of US $10.4 million, as announced on 14 November 2017.

The Company currently expects that this additional reserve will result in an approximate further decrease of 3.8% in the NAV per Ordinary Share calculated as at 30 September 2017. The reserve will be included in the 31 October 2017 NAV to be published by the Company shortly. 

As noted above, the Company is applying the reserve solely against its indirect exposure to Argon. Based on investor statements as at 31 October 2017 provided by Princeton and the reserves taken to date, the Company estimates that its exposure to the imposed Argon side pocket capital account (as described in the Company's half year accounts) is now US $3.8 million while the current indirect loan exposure (net of anticipated expenses) to Argon is approximately US $2.4 million. The Company notes that imposition of the Argon side pocket as between the Company and other Princeton investors remains subject to the ongoing arbitration proceedings. 

Shareholders should note that Princeton has not itself taken this additional reserve against the Company's investment and this reserve is calculated using the Company's and its investment manager's own analysis of the information received. The valuation (of both the Argon investment and other investments in the Princeton portfolio) may change based on the information received in the future.

This announcement contains inside information.

 

For further information, please contact:

Link Company Matters Limited

+44 (0)1392 477 510

Secretary

Ranger Capital Group

Via Redleaf PR

Bill Kassul

Scott Canon

 

 

Liberum Capital Limited

Joshua Hughes

+44 (0)20 3100 2000

Media Enquiries

Redleaf Communications

+44 (0)20 7382 4730

Elisabeth Cowell

Robin Tozer

 

IMPORTANT INFORMATION

The actual outcome of any legal proceedings may be materially affected by new information coming to light following the date of this announcement. Any views contained herein are based on the Company's understanding of the relevant proceedings as of the date of this announcement.

END OF ANNOUNCEMENT

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUEANALFLAXFFF
Date   Source Headline
18th Jun 20187:30 amRNSBoard Changes
12th Jun 20183:09 pmRNSMonthly Update
12th Jun 20183:07 pmRNSNet Asset Value(s)
12th Jun 20187:00 amBUSOaktree Releases Open Letter to Shareholders: Changed Landscape Reinforces Need for Board Change
11th Jun 20183:35 pmRNSNotice of AGM
11th Jun 20187:00 amRNSManagement Review Process Update
8th Jun 20187:00 amBUSOaktree Releases Open Letter to Ranger Shareholders
6th Jun 20184:49 pmRNSResponse to Fourth Oaktree Letter
6th Jun 20187:11 amBUSOaktree Releases Open Letter to Ranger Shareholders
16th May 20184:31 pmRNSNotice of AGM
15th May 20182:46 pmRNSMonthly Update
15th May 20182:34 pmRNSNet Asset Value(s)
14th May 20183:51 pmRNSHolding(s) in Company
8th May 20187:00 amRNSResponse to Third Oaktree Letter
8th May 20187:00 amBUSOaktree Nominates Two Additional Directors for Upcoming Ranger Shareholder Annual General Meeting
4th May 20187:00 amBUSOaktree Releases an Open Letter to Ranger Shareholders following Proposal from RDL Board to Appoint Ares as Investment Manager
1st May 20187:47 amRNSManagement Review Update - Replacement
1st May 20187:18 amRNSManagement Review Update
30th Apr 20187:00 amRNSPortfolio Update
30th Apr 20187:00 amRNSAnnual Financial Report
27th Apr 201810:55 amRNSResponse to Second Oaktree Letter
27th Apr 20187:00 amBUSOaktree Sends Further Letter to Ranger Board of Directors
24th Apr 20182:58 pmRNSResponse to Oaktree
24th Apr 20181:54 pmBUSOaktree Sends Letter to Ranger Board of Directors Regarding Strategic Review
13th Apr 20182:43 pmRNSPortfolio Update
5th Apr 20184:40 pmRNSMonthly Update
5th Apr 20184:36 pmRNSNet Asset Value(s)
3rd Apr 20183:57 pmRNSHolding(s) in Company
3rd Apr 20183:56 pmRNSHolding(s) in Company
12th Mar 20187:48 amRNSPortfolio Update
6th Mar 20184:24 pmRNSMonthly Update
6th Mar 20184:20 pmRNSNet Asset Value(s)
1st Mar 20187:00 amRNSDividend Declaration
27th Feb 20183:06 pmRNSIFRS Implementation
23rd Feb 20182:49 pmRNSHolding(s) in Company
23rd Feb 20182:19 pmRNSHolding(s) in Company
6th Feb 20185:11 pmRNSMonthly Update
6th Feb 20185:09 pmRNSNet Asset Value(s)
6th Feb 20184:21 pmRNSHolding(s) in Company
29th Jan 20188:15 amRNSExternal Management & Princeton Arbitration Update
11th Jan 20184:43 pmRNSPortfolio Update
5th Jan 20183:47 pmRNSMonthly Update
5th Jan 20183:38 pmRNSNet Asset Value(s)
27th Dec 20173:44 pmRNSDirector/PDMR Shareholding
20th Dec 20174:22 pmRNSMonthly Update
20th Dec 20174:20 pmRNSNet Asset Value(s)
15th Dec 20173:38 pmRNSHolding(s) in Company
15th Dec 20177:00 amRNSPortfolio Update
14th Nov 20177:00 amRNSPrinceton - Portfolio Update
14th Nov 20177:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.